The phase 1 trial results, published Feb. 19 in Nature, evaluated the personalized mRNA neoantigen vaccine autogene cevumeran in combination with surgery, immunotherapy drug atezolizumab and ...

A gene called high mobility group A1 (HMGA1) may be the key that opens the door to the development of colon cancer, according ...

Zealand Pharma reports 2024 results but no partnering deal for petrelintide. CEO Adam Steensberg remains confident despite ...

An innovative organoid model mirrors the pancreas' complexity, generating all three key cell types to explore development and ...

Pancreatic cancer can cause back pain that spreads from the abdomen. It often affects the middle of the back and may feel like a dull ache. For some people, the pain may come and go. Pancreatic ...

However, positive early-stage results for its once weekly Amycretin obesity drug, which similarly employs the amylin pancreas hormone, led the stock higher last month. Novo Nordisk said Wednesday ...